Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05312814 · ClinicalTrials.gov registry record

Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.

A clinical trial, sponsored by Natera.

Completed
Registry status
137
Enrollment target

NCT05312814 is a clinical trial that has completed, run by Natera. The registered enrollment target is 137 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05312814 has completed, sponsored by Natera.

COMPLETED
Registry status
137 participants
Enrollment target

Study Summary

The ZTWINS registry study is an observational, prospective, multi-center study observing women carrying a twin pregnancy who receive snp-based non-invasive prenatal screening and zygosity assessment as part of their medical care.

Trial Details

FieldValue
Enrollment Target 137 participants
Start Date 2021-10-01
Est. Completion 2023-05-15

Sponsor

Natera

27 total trials

What the Registry Record Tells You About NCT05312814

The ClinicalTrials.gov registry entry for NCT05312814 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05312814 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05312814 about?

NCT05312814 is a clinical study titled "Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.". The ZTWINS registry study is an observational, prospective, multi-center study observing women carrying a twin pregnancy who receive snp-based non-invasive prenatal screening and zygosity assessment as part of their medical care.

What is the current status of trial NCT05312814?

This trial is currently completed. The enrollment target is 137 participants. The study started on 2021-10-01. Estimated completion is 2023-05-15.

Who is sponsoring clinical trial NCT05312814?

This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.